Highlights Net business wins in the quarter of $2,654 million; a net book to bill of 1.27, an increase of 9.9% on quarter one 2023. Closing backlog of $23.4 billion, an increase of 2.5% on quarter four 2023 and 10.1% on quarter one 2023. Quarter one revenue of $2,090.4 million representing an increase of 5.7% on prior year revenue and 5.4% on a constant currency basis. Quarter one adjusted EBITDA of $444.0 million or 21.2%... Read More

DUBLIN / Apr 03, 2024 / Business Wire / ICON plc (NASDAQ: ICLR) , a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in quarter four this year for a new opportunity outside of the CRO industry. Brendan has held the role since 2012 and will remain with the company in his current role as CFO to ensure a smooth... Read More

DUBLIN / Mar 25, 2024 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the market closes on Wednesday, April 24, 2024. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, April 25, 2024 at 8:00am ET. Any... Read More

DUBLIN / Feb 26, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen 44 th Annual Healthcare Conference on Tuesday, March 5, 2024 at 11:10 am ET and Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays 26 th Annual Global Healthcare Conference on... Read More

Highlights Net business wins in the quarter of $2,531 million; a net book to bill of 1.22. Full year net business wins of $9,946 million; a net book to bill of 1.22. Closing backlog of $22.8 billion, an increase of 2.4% on quarter three 2023 and an increase of 10.0% on quarter four 2022. Quarter four revenue of $2,066.2 million representing an increase of 5.3% on prior year revenue. Full year revenue of $8,120.2 million... Read More

DUBLIN / Jan 30, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the fourth quarter and full year 2023 results after the market closes on Wednesday, February 21, 2024. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday,... Read More

DUBLIN / Jan 24, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent industry survey of over 100 professionals engaged in obesity-related clinical research to measure industry opinions on trends within this therapeutic area. The majority of respondents believe the future of obesity therapies lies in trials... Read More

Highlights Full Year 2024 Revenue guidance in the range of $8,400 - $8,800 million, representing growth of 3.2% – 8.1% over Full Year 2023 Revenue guidance midpoint. Full Year 2024 adjusted earnings per share 1 guidance in the range of $14.50 - $15.30, representing growth of 13.5% – 19.8% over Full Year 2023 adjusted earnings per share guidance midpoint. DUBLIN / Jan 09, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR), a... Read More

Survey points to importance of strategic engagement with investors and effective asset development strategies to optimise funding DUBLIN / Jan 08, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech funding” whitepaper. This provides an overview of the current state of play for biotech companies and the research... Read More

DUBLIN / Jan 04, 2024 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15pm PST/8.15pm EST. Any changes to these events and links to the live webcasts (where available) will be posted on the Investor... Read More

Healthcare intelligence organisation earns recognition as employer of choice and leading innovator in the clinical trial industry DUBLIN / Dec 18, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half of 2023 with positive recognition as a top-rated employer and leader in clinical trial innovation. In recognition of its... Read More

DUBLIN / Dec 07, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Moody's Investors Service ("Moody's") upgraded all of ICON plc’s instrument ratings to Baa3 with a stable outlook. This reflects the stronger credit profile of the ICON Group, which Moody’s now views as comparable in aggregate to Baa3 peers. The Baa3 rating of all... Read More

DUBLIN / Nov 08, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Tuesday, November 14, 2023 at 2:00pm GMT. Mr. Brendan Brennan will also present at the Evercore HealthCONx Conference on Wednesday, November 29, 2023, at... Read More

Highlights Net business wins in the quarter of $2,581 million; a net book to bill of 1.26 or 1.22 on a trailing twelve month basis and an increase of 10% on quarter three 2022. Closing backlog of $22.2 billion, an increase of 2.6% on quarter two 2023 and an increase of 10.0% on quarter three 2022. Quarter three revenue of $2,055.1 million representing an increase of 5.8% on prior year revenue. YTD revenue of $6,053.9 million... Read More

DUBLIN / Oct 12, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that S&P Global Ratings (S&P) upgraded ICON to an investment grade credit rating of BBB- with a stable outlook, based on operating performance and deleveraging. S&P upgraded ICON from a ‘BB+’ rating to a ‘BBB-’, raising their long-term issuer credit rating and their... Read More

DUBLIN / Sep 21, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the third quarter 2023 after the market closes on Wednesday, October 25, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 26, 2023 at 8:00am ET.... Read More

Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards DUBLIN / Sep 20, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’s proprietary tokenisation... Read More

DUBLIN / Sep 13, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to evaluate the... Read More

DUBLIN / Sep 06, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird Global Healthcare Conference on Wednesday, September 13, 2023 at 10:15 am ET. Any changes to this event and links to the live webcasts (where available) will be posted on the Investor section of... Read More

DUBLIN / Jul 26, 2023 / Business Wire / ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading healthcare intelligence and clinical research organisation, today announced that all resolutions at the Annual General Meeting of the Company (AGM) held on July 25, 2023 (which resolutions had all been recommended by the Board) were all duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to... Read More

Highli ghts Net business wins in the quarter of $2,419 million; a net book to bill of 1.20 or 1.21 on a trailing twelve month basis. Closing backlog of $21.7 billion, an increase of 2.2% on quarter one 2023 or an increase of 8.5% on quarter two 2022. Quarter two revenue of $2,020.3 million representing an increase of 4.4% on prior year revenue and 4.3% on a constant currency organic basis. YTD revenue of $3,998.8 million... Read More

Leading healthcare intelligence organisation most awarded CRO in 2023 CRO Leadership Awards DUBLIN / Jul 13, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has received positive recognition from leading business and industry organisations as a leading CRO of choice and a top-rated employer in the first half of 2023. For its excellent performance in... Read More

DUBLIN / Jun 27, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2023 after the market closes on Wednesday, July 26, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, July 27, 2023 at 8:00am ET. Any... Read More

Latest features support greater patient centricity and speed in study start-up DUBLIN / Jun 26, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced the latest release of its Digital Platform . The platform supports seamless integration of ICON patient, site and sponsor services with the delivery of harmonised data and can be customised... Read More

DUBLIN / Jun 26, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR), is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens today, Monday, June 26. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, ranking them by total market capitalization, including both the Russell 3000 ® and... Read More

DUBLIN / May 31, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 2:40pm CT and Mr. Brendan Brennan, CFO of ICON plc, will attend the UBS Healthcare Services Conference on Wednesday, June 28,... Read More

DUBLIN / May 16, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2022 Environmental, Social and Governance (ESG) Report . The company’s ICON Cares initiative incorporates its ESG, Diversity, Inclusion and Belonging and Corporate Social Responsibility initiatives under one program. The report provides an overview of... Read More

Highlights Net business wins in the quarter of $2,415 million; a net book to bill of 1.22. Closing backlog of $21.2 billion, an increase of 2.4% on quarter four 2022 or an increase of 8.4% on quarter one 2022. First quarter revenue of $1,978.6 million representing an increase of 4.0% on prior year revenue and 5.3% on a constant currency organic basis. Quarter one adjusted EBITDA of $399.1 million or 20.2% of revenue, an... Read More

DUBLIN / Mar 29, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2023 after the market closes on Wednesday, April 26, 2023. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, April 27, 2023 at 8:00am ET. Any... Read More

BALLERUP, Denmark & DUBLIN / Mar 10, 2023 / Business Wire / LEO Pharma , a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution... Read More

DUBLIN / Feb 27, 2023 / Business Wire / ICON plc , (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare Conference on Thursday, March 2, 2023 at 2pm ET. Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays Global Healthcare Conference on Wednesday, March 15, 2023. The... Read More

DUBLIN, Ireland / Feb 22, 2023 / Business Wire / ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the fourth quarter and year ended December 31, 2022. CEO, Dr. Steve Cutler commented, “ ICON continued its positive momentum in the fourth quarter of 2022, with 7.6% constant currency revenue growth year over year, and delivering on our... Read More

ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the 41 st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 5:15pm PST/ 8.15pm EST. Any changes to these events and links to the live webcasts (where available) will be posted on the Investor section of our website under “ Events... Read More

TROY, Mich. , Nov. 28, 2022 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Icon PLC (NYSE: ICLR) as its "Stock to Study" and Williams-Sonoma Inc. (NYSE: WSM) as its "Undervalued Stock" in the January- February 2023 issue for investors' informational and educational use. "As we celebrate the holiday season, our wish for all Americans is that they gift... Read More

DUBLIN--( BUSINESS WIRE )-- ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022. The presentation will be webcast live from 08:00am EST. Any changes to these events and links to the live webcasts (where available) will be... Read More